⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPRX News
Kiora Pharmaceuticals, Inc. Common Stock
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
PSTV
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
Kiora Pharmaceuticals Announces Management Team Changes Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
Gradial Launches GEO Agent With Built-In Execution to Help Brands Win in AI Search
globenewswire.com
TMUS
PRU
WFC
KPRX
Joint Commission names new members to boards of directors for Joint Commission Resources and National Quality Forum
globenewswire.com
KPRX